Analyzing IL-2-induced vascular leakage with an irAOP as tool
Immune-related adverse outcome pathways (irAOPs) are a toxicological tool for the structuring of complex immunological mechanisms. The EU-funded IMI-project imSAVAR analyses the applicability of irAOPs in pre-clinical safety assessment of immunotherapies. Here, we use immunotherapy with interleukin...
Saved in:
| Main Authors: | Patricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann, Remi Villenave, Katherina Sewald, Zoe Waibler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Immunotoxicology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/1547691X.2024.2369123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using irAOP for non-clinical safety evaluation of biotechnology-derived pharmaceuticals and ATMPs: a paradigm shift into a systematic and holistic framework
by: Armin Braun, et al.
Published: (2024-12-01) -
An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system
by: Vanessa Neuhaus, et al.
Published: (2024-12-01) -
Revival of recombinant IL-2 therapy – approaches from the past until today
by: Luise A. Roser, et al.
Published: (2024-12-01) -
Divergent Leakage Features of Anticyclonic and Cyclonic Mesoscale Eddies
by: Yanjiang Lin, et al.
Published: (2025-04-01) -
Rethinking Disclosure Prevention with Pointwise Maximal Leakage
by: Sara Saeidian, et al.
Published: (2025-03-01)